"Putamen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS.
| Descriptor ID |
D011699
|
| MeSH Number(s) |
A08.186.211.730.885.287.249.487.550.784
|
| Concept/Terms |
Putamen- Putamen
- Putamens
- Nucleus Putamen
- Nucleus Putamens
- Putamen, Nucleus
- Putamens, Nucleus
|
Below are MeSH descriptors whose meaning is more general than "Putamen".
Below are MeSH descriptors whose meaning is more specific than "Putamen".
This graph shows the total number of publications written about "Putamen" by people in this website by year, and whether "Putamen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2010 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Putamen" by people in Profiles.
-
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder. J Affect Disord. 2024 Jul 15; 357:107-115.
-
Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2022 03; 9(2).
-
Switching between internally and externally focused attention in obsessive-compulsive disorder: Abnormal visual cortex activation and connectivity. Psychiatry Res Neuroimaging. 2017 Jul 30; 265:87-97.
-
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Ann Neurol. 2015 Aug; 78(2):248-57.
-
Aberrant Monoaminergic System in Thyroid Hormone Receptor-? Deficient Mice as a Model of Attention-Deficit/Hyperactivity Disorder. Int J Neuropsychopharmacol. 2015 Jan 22; 18(7):pyv004.
-
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010 Dec; 9(12):1164-1172.
-
Diffuse damage in pediatric traumatic brain injury: a comparison of automated versus operator-controlled quantification methods. Neuroimage. 2010 Apr 15; 50(3):1017-26.
-
Volume and iron content in basal ganglia and thalamus. Hum Brain Mapp. 2009 Aug; 30(8):2667-75.
-
Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet. 2005 Aug 05; 137B(1):5-16.
-
White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol. 2005 Jun; 18(2):102-7.